• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zoetis (NY: ZTS )

    174.63 -2.41 (-1.36%)
    Official Closing Price Updated: 4:10 PM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Zoetis

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Expert Outlook: Zoetis Through The Eyes Of 4 Analysts
    Via Benzinga
    Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors
    From Zoetis Inc.
    Via Business Wire
    Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
    The S&P 500 rose last month, but these stocks didn't. 
    Via The Motley Fool
    Topics Stocks
    Exposures US Equities
    Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
    Via Benzinga
    Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results
    From Zoetis Inc.
    Via Business Wire
    Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
    Via Benzinga
    Looking Into Zoetis's Recent Short Interest
    Via Benzinga
    Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine
    The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoetis' Librela monoclonal antibody for osteoarthritis pain relief in dogs... 
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Zoetis to Participate in the Barclays Global Healthcare Conference
    From Zoetis Inc.
    Via Business Wire
    1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
    Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio. 
    Via The Motley Fool
    Topics Stocks
    Exposures US Equities
    4 Analysts Have This To Say About Zoetis
    Via Benzinga
    (ZTS) - Analyzing Zoetis's Short Interest
    Via Benzinga
    Is ZOETIS INC (NYSE:ZTS) a Strong Candidate for Quality Investing?
    Why Quality Investors Should Delve into ZOETIS INC (NYSE:ZTS) for Investment Opportunities. 
    Via Chartmill
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
    Via Benzinga
    Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit
    From Zoetis Inc.
    Via Business Wire
    Zoetis (ZTS) Q4 2023 Earnings Call Transcript
    ZTS earnings call for the period ending December 31, 2023. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday?
    Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report. 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    What 4 Analyst Ratings Have To Say About Zoetis
    Via Benzinga
    Will ZOETIS INC Break Out? A Technical Analysis Perspective.
    ZOETIS INC (NYSE:ZTS) has a strong technical rating of 10 out of 10, indicating a potential breakout. 
    Via Chartmill
    Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins
    Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products. 
    Via Benzinga
    Zoetis Reports Fourth Quarter and Full Year 2023 Results
    From Zoetis Inc.
    Via Business Wire
    Zoetis Declares Second Quarter 2024 Dividend
    From Zoetis Inc.
    Via Business Wire
    Drug Maker AbbVie Stock Sees RS Rating Jump To 81
    AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81. 
    Via Investor's Business Daily
    Earnings Scheduled For February 13, 2024
    Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
    Via Benzinga
    Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings
    Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level. 
    Via Investor's Business Daily
    Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025
    The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue,... 
    Via Benzinga
    AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow
    AbbVie shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
    Via Investor's Business Daily
    4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
    These stocks never seem to go on sale. Here's why I'm buying them anyway. 
    Via The Motley Fool
    Zoetis Wins 2024 Catalyst Award
    From Zoetis Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.